Phase Ib Study of MEM-288 Oncolytic Virus in Combination with Nivolumab in Non-Small Cell Lung Cancer (NSCLC)
Research Grant
Administered By
Medicine, Medical Oncology
Awarded By
Bristol-Myers Squibb Foundation
Start Date
October 16, 2023
End Date
January 15, 2025
Administered By
Medicine, Medical Oncology
Awarded By
Bristol-Myers Squibb Foundation
Start Date
October 16, 2023
End Date
January 15, 2025